Navigation Links
Caffeine May Lower Ovarian Cancer Risk
Date:1/22/2008

feine a day -- about two or more cups of coffee or five 12-ounce sodas -- had twice the miscarriage risk of those who avoided caffeine entirely. Even smaller amounts increased risk, with women drinking less than 200 milligrams of caffeine a day showing more than a 40 percent increased risk of miscarriage, compared to those who took in no caffeine.

The study was published online in the January issue of the American Journal of Obstetrics and Gynecology.

More information

To learn more about ovarian cancer symptoms, visit the Ovarian Cancer National Alliance.



SOURCES: Shelley S. Tworoger, Ph.D., assistant professor, medicine and epidemiology, Harvard Medical School and Harvard School of Public Health, and associate epidemiologist, Brigham and Women's Hospital, Boston; Sherry Salway Black, executive director, Ovarian Cancer National Alliance, Washington, D.C.; March 1, 2008, Cancer; Jan. 21, 2008, American Journal of Obstetrics and Gynecology, online


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Ovarian cancer risk not affected by alcohol and smoking, but reduced by caffeine
2. Once Again, Caffeine Linked to Miscarriage
3. New Kaiser Permanente study fortifies caffeines link to miscarriage
4. Kaiser Permanente study shows link between caffeine and miscarriage
5. Bedford Laboratories(TM) Announces the Acquisition of CAFCIT(R) (Caffeine Citrate) Injection CAFCIT(R) (Caffeine Citrate) Oral Solution
6. Caffeine cream tones thighs
7. Caffeine Therapy Boosts Preemies Outcomes
8. Caffeine Survey Reveals Most, Least Caffeinated Cities
9. Caffeine Plus Acetaminophen Toxic for Some
10. Lowering Co-Pays on Some Drugs Help Fight Chronic Diseases
11. Better access to cool caps improves outcomes, lowers cost of treating asphyxia in newborns
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 2BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 3BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 4Drug Candidates in Pipeline Offer Potential for Parkinson's Disease Therapeutics Market, Says Frost & Sullivan 2Drug Candidates in Pipeline Offer Potential for Parkinson's Disease Therapeutics Market, Says Frost & Sullivan 3Reportlinker Adds Bulk Paclitaxel - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Bulk Paclitaxel - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Bulk Paclitaxel - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Bulk Paclitaxel - A Global Update of Market Trends & Opportunities 5dazzlesmile Sues Epic Advertising and Jesse Willms 62136 1dazzlesmile Sues Epic Advertising and Jesse Willms 62136 2For Millions With Untreated Hearing Loss Holiday Season Can be Especially Difficult 6542 1For Millions With Untreated Hearing Loss Holiday Season Can be Especially Difficult 6542 2Crosstalk between critical cell signaling pathways holds clues to tumor invasion and metastasis 62132 1Crosstalk between critical cell signaling pathways holds clues to tumor invasion and metastasis 62132 2Crosstalk between critical cell signaling pathways holds clues to tumor invasion and metastasis 62132 3